Bruker Corporation Reports First Quarter 2010 Financial Results

Bruker Corporation Reports First

Quarter 2010 Financial Results

BILLERICA, Mass., April 29, 2010 (BUSINESS WIRE)

Bruker Corporation (NASDAQ: BRKR) today reported financial results for

the first quarter ended March 31, 2010.

In the first quarter of 2010, Bruker s revenue was $277.7 million, an

increase of 20.5% compared to revenue of $230.5 in the first quarter of

2009. Excluding the effects of foreign

currency translation, first quarter 2010 revenue increased by 12.4%

year-over-year. In the first quarter of

2010, GAAP revenue increased by 16.4% year-over-year for the Bruker Scientific

Instruments (BSI) segment, and by 156% year-over-year for the Bruker Energy &

Supercon Technologies (BEST) segment.

Bruker s operating income in the first quarter of 2010 was $26.9

million, compared to $14.3 million in the first quarter of 2009. GAAP operating margin for the BSI segment in

the first quarter of 2010 was 10.6%, compared to 7.2% in the first quarter of

Bruker s GAAP net income for the first quarter of 2010 was $16.1

million, or $0.10 per diluted share, compared to net income of $8.4 million, or

$0.05 per diluted share, in the first quarter of 2009. Included in Bruker s earnings per share (EPS)

for the first quarter 2010 was non-cash stock-based compensation expense of

($0.01) per diluted share, the same as in the first quarter of 2009. EPS for the BSI segment in the first quarter

of 2010 was $0.10, compared to $0.06 in the first quarter of 2009. EPS for the first quarter of 2010 for the

BEST segment was $0.00, compared to a loss of ($0.02) in the first quarter of

Bruker cash flow from operations for the first quarter 2010 was $5.5

million, compared to $13.1 million in the first quarter of 2009. Bruker ended the first quarter of 2010 with

cash, cash equivalents and restricted cash of $206.6 million, and net cash of

Frank Laukien, President and CEO, commented: We are very pleased with

our first quarter 2010 results, with strong year-over-year revenue growth and

significant improvements in gross and operating margins. All four operating divisions in our BSI

segment delivered double-digit growth year-over-year, and our BEST segment had

triple-digit growth for the second quarter in a row. The industrial and applied markets continued

to improve gradually during the first quarter, and overall we recorded healthy

new order bookings, including more than $10 million in additional U.S.

stimulus orders, all of which contributed to strong backlog at the end of the

EARNINGS CONFERENCE CALL

Bruker Corporation will host an

operator-assisted earnings conference call at 9:00 a.m. Eastern Daylight

Time on Thursday, April 29, 2010.

To listen to the webcast, investors can go to http://ir.bruker.com and

click on the live web broadcast symbol.

The webcast will be available through the Company web site for 30

days. Investors can also listen and

participate on the telephone in the US and Canada by calling 800-688-0796, or

+1-617-614-4070 outside the US and Canada.

Investors should refer to the Bruker Earnings Call. A telephone replay of the conference call

will be available one hour after the conference call by dialing 888-286-8010 in

the US and Canada, or +1-617-801-6888 outside the US and Canada, and then

entering replay pass code 62891829. For more information, please visit

Any statements contained in this presentation that do not describe

historical facts may constitute forward-looking statements as that term is

defined in the Private Securities Litigation Reform Act of 1995. Any

forward-looking statements contained herein are based on current expectations,

but are subject to risks and uncertainties that could cause actual results to

differ materially from those projected, including, but not limited to, risks

and uncertainties relating to adverse changes in conditions in the global

economy and volatility in the capital markets, the integration of businesses we

have acquired or may acquire in the future, changing technologies, product

development and market acceptance of our products, the cost and pricing of our

products, manufacturing, competition, dependence on collaborative partners and

key suppliers, capital spending and government funding policies, changes in

governmental regulations, realization of anticipated benefits from economic

stimulus programs, intellectual property rights, litigation, and exposure to

foreign currency fluctuations and other risk factors discussed from time to

time in our filings with the Securities and Exchange Commission. These and

other factors are identified and described in more detail in our filings with

the SEC, including, without limitation, our annual report on Form 10-K for

the year ended December 31, 2009, our most recent quarterly reports on Form 10-Q

and our current reports on Form 8-K. We expressly disclaim any intent or

obligation to update these forward-looking statements other than as required by

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

Reconciliation of BSI and BEST reportable segments to

the consolidated results of Bruker Corporation for the quarters ended March 31,

2010 and 2009 (unaudited)

(in millions, except per share data)